Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus post-11-week aspirin for prevention of pre-eclampsia in high-risk pregnant women
IRCT20221126056611N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin in preeclampsia (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Incidence of preeclampsia. Started Jan 2023; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20221126056611N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221126056611N1.